Overview
I am a Research Associate and Trial Manager in the Infections, Inflammation & Immunity (I3) Research division at the Centre for Trials Research, College of Biomedical and Life Sciences, Cardiff University.
My research interests span across the I3 themes, having worked on the following studies; POETIC, PACE, INDUCE, THESEUS and PriMUS; Studies and trials - Centre for Trials Research - Cardiff University.
I have extensive knowledge and experience of trial methodology and governance within both the primary care and secondary care settings.
Publication
2024
- Sewell, B. et al. 2024. Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multicentre, parallel-arm, open, individually randomised, controlled PACE trial. BMJ Open 14(11), article number: e084144. (10.1136/bmjopen-2024-084144)
- Hasan, S. B. et al. 2024. Feasibility of daily pain measurement using text messages in Hidradenitis Suppurativa clinical trials; Data from THESEUS study. British Journal of Dermatology 190(5), pp. 775-777., article number: ljae057. (10.1093/bjd/ljae057)
- Ingram, J. R. et al. 2024. Treatment of hidradenitis suppurativa evaluation study (THESEUS): a prospective cohort study. British Journal of Dermatology 190(3), pp. 382-391. (10.1093/bjd/ljad388)
- Edwards, A. et al. 2024. Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study. Health Technology Assessment
2023
- Ingram, J. R. et al. 2023. Treatment of hidradenitis suppurativa evaluation study: the THESEUS prospective cohort study. Health Technology Assessment 27, article number: 30. (10.3310/HWNM2189)
- Leighton, P. et al. 2023. Research priorities in the management of Hidradenitis Suppurativa [Research Letter]. British Journal of Dermatology 189(3), pp. 343-345. (10.1093/bjd/ljad152)
2021
- Gillespie, D. et al. 2021. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice 71(705), pp. e266-e272. (10.3399/BJGP.2020.0823)
2019
- Butler, C. C. et al. 2019. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. New England Journal of Medicine 381, pp. 111-120. (10.1056/NEJMoa1803185)
2017
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67(665), pp. e830-e841. (10.3399/bjgp17X693641)
- Bates, J. et al. 2017. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18, article number: 422. (10.1186/s13063-017-2144-8)
Articles
- Sewell, B. et al. 2024. Cost-effectiveness of C-reactive protein point of care testing for safely reducing antibiotic consumption for acute exacerbations of chronic obstructive pulmonary disease as part of the multicentre, parallel-arm, open, individually randomised, controlled PACE trial. BMJ Open 14(11), article number: e084144. (10.1136/bmjopen-2024-084144)
- Hasan, S. B. et al. 2024. Feasibility of daily pain measurement using text messages in Hidradenitis Suppurativa clinical trials; Data from THESEUS study. British Journal of Dermatology 190(5), pp. 775-777., article number: ljae057. (10.1093/bjd/ljae057)
- Ingram, J. R. et al. 2024. Treatment of hidradenitis suppurativa evaluation study (THESEUS): a prospective cohort study. British Journal of Dermatology 190(3), pp. 382-391. (10.1093/bjd/ljad388)
- Edwards, A. et al. 2024. Development of a clinical decision support tool for Primary care Management of lower Urinary tract Symptoms in men: the PriMUS study. Health Technology Assessment
- Ingram, J. R. et al. 2023. Treatment of hidradenitis suppurativa evaluation study: the THESEUS prospective cohort study. Health Technology Assessment 27, article number: 30. (10.3310/HWNM2189)
- Leighton, P. et al. 2023. Research priorities in the management of Hidradenitis Suppurativa [Research Letter]. British Journal of Dermatology 189(3), pp. 343-345. (10.1093/bjd/ljad152)
- Gillespie, D. et al. 2021. Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial. British Journal of General Practice 71(705), pp. e266-e272. (10.3399/BJGP.2020.0823)
- Butler, C. C. et al. 2019. C-reactive protein testing to guide antibiotic prescribing for COPD exacerbations. New England Journal of Medicine 381, pp. 111-120. (10.1056/NEJMoa1803185)
- Butler, C. C. et al. 2017. Variations in presentation, management, and patient outcomes of urinary tract infection: a prospective four-country primary care observational cohort study. British Journal of General Practice 67(665), pp. e830-e841. (10.3399/bjgp17X693641)
- Bates, J. et al. 2017. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial. Trials 18, article number: 422. (10.1186/s13063-017-2144-8)